Pay in 4 interest-free payments of $5.67 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Poll: 1 in 8 Adults Say They Are Currently Taking a GLP-1 Drug for Weight Loss, Diabetes or Another Condition, Even as Half Say the Drugs Are Difficult to Afford Most Doubt the Trump Administration Will Lower Drug Costs for People Like Them, Though Three-Fourths of Republicans Expect It Will About one in eight adults (12%) say that they are currently taking a GLP-1 drug such as Ozempic or Wegovy either to lose weight or treat a chronic condition, an increase from 18 months ago, though the high costs of the medications remain a concern, a new KFF Health Tracking Poll finds
Who May Be Interested in Semaglutide
Altered bioenergetics and mitochondrial dysfunction of monocytes in patients with COVID-19 pneumonia
The challenge is that cost pressure can lead people toward dosing strategies that havent been carefully studied, especially when they are trying to balance financial concerns with medical evidence
